These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38749856)

  • 1. Clinical Characteristics and 2-Year Outcomes of Chronic Obstructive Pulmonary Disease Patients With High Blood Eosinophil Counts: A Population-based Prospective Cohort Study in China.
    Wu X; Deng Z; Wu F; Zheng Y; Huang P; Yang H; Zhao N; Dai C; Peng J; Lu L; Zhou K; Wan Q; Tang G; Chen S; Huang Y; Yang C; Yu S; Ran P; Zhou Y
    Arch Bronconeumol; 2024 Jul; 60(7):402-409. PubMed ID: 38749856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stability of blood eosinophils in stable chronic obstructive pulmonary disease: a retrospective study in Belgian primary care.
    Van Rossem I; Vandevoorde J; Hanon S; Deridder S; Vanderhelst E
    BMC Pulm Med; 2020 Jul; 20(1):200. PubMed ID: 32698819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the role of blood eosinophil count in patients with severe acute exacerbation of chronic obstructive pulmonary disease hospitalized in a Tunisian Center].
    Saad AB; Khemakhem R; Mhamed SC; Fahem N; Migaou A; Joobeur S; Rouatbi N
    Pan Afr Med J; 2019; 34():138. PubMed ID: 33708307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study.
    Cui Y; Zhang W; Ma Y; Zhan Z; Chen Y
    Respir Res; 2021 Nov; 22(1):301. PubMed ID: 34819051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
    Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort.
    LeMaster WB; Quibrera PM; Couper D; Tashkin DP; Bleecker ER; Doerschuk CM; Ortega VE; Cooper C; Han MK; Woodruff PG; O'Neal WK; Anderson WH; Alexis NE; Bowler RP; Barr RG; Kaner RJ; Dransfield MT; Paine R; Kim V; Curtis JL; Martinez FJ; Hastie AT; Barjaktarevic I
    Chest; 2023 Mar; 163(3):515-528. PubMed ID: 36343688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization.
    Viinanen A; Lassenius MI; Toppila I; Karlsson A; Veijalainen L; Idänpään-Heikkilä JJ; Laitinen T
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2409-2421. PubMed ID: 31749614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between COPD exacerbations and lung function decline during maintenance therapy.
    Kerkhof M; Voorham J; Dorinsky P; Cabrera C; Darken P; Kocks JW; Sadatsafavi M; Sin DD; Carter V; Price DB
    Thorax; 2020 Sep; 75(9):744-753. PubMed ID: 32532852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study.
    Miravitlles M; Soler-Cataluña JJ; Soriano JB; García-Río F; de Lucas P; Alfageme I; Casanova C; Rodríguez González-Moro JM; Sánchez-Herrero MG; Ancochea J; Cosío BG
    Respir Res; 2022 Mar; 23(1):49. PubMed ID: 35248041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
    Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
    Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
    Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
    Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.
    van Geffen WH; Tan DJ; Walters JA; Walters EH
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD011600. PubMed ID: 38054551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies.
    Criner GJ; Celli BR; Singh D; Agusti A; Papi A; Jison M; Makulova N; Shih VH; Brooks L; Barker P; Martin UJ; Newbold P
    Lancet Respir Med; 2020 Feb; 8(2):158-170. PubMed ID: 31575508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
    Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
    COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
    Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
    J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype of Asthma-COPD Overlap in COPD and Severe Asthma Cohorts.
    Joo H; Park SY; Park SY; Park SY; Kim SH; Cho YS; Yoo KH; Jung KS; Rhee CK
    J Korean Med Sci; 2022 Aug; 37(30):e236. PubMed ID: 35916048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease.
    Shin SH; Park HY; Kang D; Cho J; Kwon SO; Park JH; Lee JS; Oh YM; Sin DD; Kim WJ; Lee SD;
    Respir Res; 2018 Jul; 19(1):134. PubMed ID: 30001715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma.
    Li A; Chan HP; Gan PXL; Liew MF; Wong WSF; Lim HF
    Korean J Intern Med; 2021 Nov; 36(6):1305-1319. PubMed ID: 34634855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.